Skip to content
2000
Volume 19, Issue 2
  • ISSN: 1872-2105
  • E-ISSN: 2212-4020

Abstract

Background

In the development of drug delivery systems, drugs' solubility remains the most challenging constraint. Many newly synthesized chemical compounds are available, but they involve low solubility and poor permeability restrictions. Among various drug delivery systems, the utilization of solid dispersion technologies has become more focused due to their promising benefits.

Objective

This technology has attracted extensive attention for dissolution rate improvement along with substantial bioavailability enhancement of poorly water-soluble drug candidates.

Methods

Many approaches have been employed for preparing solid dispersions, such as the melting method, hot melt extrusion, solvent evaporation process, fusion and kneading method, spray drying technique, co-grinding and freeze drying, supercritical fluid technology, .

Results

A wide variety of hydrophilic and hydrophobic materials are available as carriers, which are employed in the formulation of solid dispersions. Depending on the carrier characteristics, immediate-release solid dispersions and/or controlled-release solid dispersions can be formulated. Multiple hydrophilic materials have been explored for heightening dissolution features with enhanced bioavailability of poorly water-soluble drug molecules. The availability of commercially available products further validates the utility of solid dispersion technology in drug delivery systems.

Conclusion

In the current manuscript, an attempt has been made to highlight the comprehensive development techniques, characterization techniques, recent solid dispersion technologies, clinical trial studies, and patented technology, along with studies heightening the dissolution behavior of numerous poorly aqueous soluble drugs. The major stability issues affecting the suitability of solid dispersions are also discussed.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/nanotec/10.2174/0118722105229356231030065938
2023-11-02
2025-09-25

  • From This Site

    /content/journals/nanotec/10.2174/0118722105229356231030065938
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BaghelS. CathcartH. O’ReillyN.J. Polymeric amorphous solid dispersions: A review of amorphization, crystallization, stabilization, solid-state characterization, and aqueous solubilization of biopharmaceutical classification system class II drugs.J. Pharm. Sci.201610592527254410.1016/j.xphs.2015.10.00826886314
     [Google Scholar]
  2. TambosiG. CoelhoP.F. LucianoS. LenschowI.C.S. ZétolaM. StulzerH.K. PezziniB.R. Challenges to improve the biopharmaceutical properties of poorly water-soluble drugs and the application of the solid dispersion technology.Materia20182342310.1590/s1517‑707620180004.0558
     [Google Scholar]
  3. DhandeL.B. DeshmukhM.T. KhopadeA.N. SheteR.V. KunjirV.V. A review on solubility enhancement by solid dispersion method.J. Drug Deliv. Ther.202111118218710.22270/jddt.v11i1.4489
     [Google Scholar]
  4. RumondorA.C.F. DhareshwarS.S. KesisoglouF. Amorphous solid dispersions or prodrugs: complementary strategies to increase drug absorption.J. Pharm. Sci.201610592498250810.1016/j.xphs.2015.11.00426886316
     [Google Scholar]
  5. GuptaH. BhandariD. SharmaA. Recent trends in oral drug delivery: A review.Recent Pat. Drug Deliv. Formul.20093216217310.2174/18722110978845226719519576
     [Google Scholar]
  6. VoC.L.N. ParkC. LeeB.J. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs.Eur. J. Pharm. Biopharm.201385379981310.1016/j.ejpb.2013.09.00724056053
     [Google Scholar]
  7. LachmanL. LiebermanH. KanigJ.L. The theory and practise of industrial pharmacy.3rd Lea & Febiger1986
     [Google Scholar]
  8. IUPACCompendium of Chemical Terminology2nd (the "Gold Book") McNaughtA. D. WilkinsonA. Blackwell Scientific Publications, Oxford (1997)2019
     [Google Scholar]
  9. ViswanathanP. MuralidaranY. RagavanG. Challenges in oral drug delivery: A nano-based strategy to overcome.In: Nanostructures for Oral MedicineElsevier2017173201
     [Google Scholar]
  10. The United States Pharmacopeia, USP 30-NF 25,2007Available from: https://www.uspnf.com/official-text/proposal-statuscommentary/usp-30-nf-25
  11. British Pharmacopoeia.2009Available from: https://www.pharmacopoeia.com/
  12. GennaroA.R. Remington. The science and practice of Pharmacy.20th Lippincott Williams and Wilkins2000208214
     [Google Scholar]
  13. AultonM.E. Pharmaceutics: The science of dosage form design.2nd Churchill Livingstone Publication20001532
     [Google Scholar]
  14. VemulaV.R. LagishettyV. LingalaS. Solubility enhancement techniques.Int. J. Pharm. Sci. Rev. Res.201054151
     [Google Scholar]
  15. ChaudharyA. NagaichU. GulatiN. SharmaV.K. KhosaR.L. Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: A recent review.J. Adv. Pharm. Educ. Res.201223267
     [Google Scholar]
  16. DeshmukhA.S. TiwariK.J. MahajanV.R. Solubility enhancement techniques for poorly water-soluble drugs.Int. J. Pharm. Sci. Nanotechnol.20171037013708
     [Google Scholar]
  17. ChaumeilJ.C. Micronization: A method of improving the bioavailability of poorly soluble drugs.Methods Find. Exp. Clin. Pharmacol.199820321121510.1358/mf.1998.20.3.4856669646283
     [Google Scholar]
  18. MullerR.H. JacobsC. KayerO. Nanosuspensions for the formulation of poorly soluble drugs. Marcel Dekker. EmulsionP. SuspensionF.N. Marti-MestresG. New York, NY, USA200038340710.1201/b14005‑13
     [Google Scholar]
  19. MullerR.H. BohmB.H.L. GrauJ. Nanosuspensions: A formulation approach for poorly soluble and poorly bioavailable drugs. Handbook of Pharmaceutical Controlled Release technology2000345357
     [Google Scholar]
  20. NashR.A. “Suspensions,” in encyclopedia of pharmaceutical technology.2nd SwarbrickJ. BoylanJ.C. New York, NY, USAMarcel Dekker200220453032
     [Google Scholar]
  21. LeuenbergerH. Spray freeze-drying-the process of choice for low water-soluble drugs?J. Nanopart. Res.200241/211111910.1023/A:1020135603052
     [Google Scholar]
  22. Merisko-LiversidgeE. LiversidgeG.G. CooperE.R. Nanosizing: A formulation approach for poorly-water-soluble compounds.Eur. J. Pharm. Sci.200318211312010.1016/S0928‑0987(02)00251‑812594003
     [Google Scholar]
  23. PatravaleV.B. DateA.A. KulkarniR.M. Nanosuspensions: A promising drug delivery strategy.J. Pharm. Pharmacol.201056782784010.1211/002235702369115233860
     [Google Scholar]
  24. ChowdaryK.P.R. MadhaviB.L.R. Novel drug delivery technologies for insoluble drugs.Indian Drugs.200542557564
     [Google Scholar]
  25. Rangel-YaguiC.O. PessoaA.Jr TavaresL.C. Micellar solubilization of drugs.J. Pharm. Pharm. Sci.20058214716516124926
     [Google Scholar]
  26. KeckC. MüllerR. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.Eur. J. Pharm. Biopharm.200662131610.1016/j.ejpb.2005.05.00916129588
     [Google Scholar]
  27. VishweshwarP. McMahonJ.A. BisJ.A. ZaworotkoM.J. Pharmaceutical co-crystals.J. Pharm. Sci.200695349951610.1002/jps.2057816444755
     [Google Scholar]
  28. BlagdenN. de MatasM. GavanP.T. YorkP. Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.Adv. Drug Deliv. Rev.200759761763010.1016/j.addr.2007.05.01117597252
     [Google Scholar]
  29. ShanN. ZaworotkoM.J. The role of cocrystals in pharmaceutical science.Drug Discov. Today2008139-1044044610.1016/j.drudis.2008.03.00418468562
     [Google Scholar]
  30. PatilS.V. SahooS.K. Pharmaceutical overview of spherical crystallization.Pharm. Lett.20102421426
     [Google Scholar]
  31. CharithaM. KulkarniG.S. PaarakhP.M. Solubility enhancement of water insoluble drugs by various techniques: A review.Int. J. Pharm. Pharm. Res.202121115
     [Google Scholar]
  32. SalawiA. Self-emulsifying drug delivery systems: A novel approach to deliver drugs.Drug Deliv.20222911811182310.1080/10717544.2022.208372435666090
     [Google Scholar]
  33. BhalaniD.V. NutanB. KumarA. Singh ChandelA.K. Bioavailability enhancement techniques for poorly aqueous soluble drugs and therapeutics.Biomedicines2022109205510.3390/biomedicines1009205536140156
     [Google Scholar]
  34. AinurofiqA. PutroD. RamadhaniD. PutraG. Do Espirito SantoL.D.C. SantoD.E. A review on solubility enhancement methods for poorly water-soluble drugs.J Rep Pharm Sci202110113714710.4103/jrptps.JRPTPS_134_19
     [Google Scholar]
  35. SharmaA. ChaudharyA. SinghB. A review on solubility enhancement by solid dispersion technique.J. Pharm. Res. Int.202133778710.9734/jpri/2021/v33i63A35217
     [Google Scholar]
  36. ColtescuA.R. ButnariuM. SaracI. The importance of solubility for new drug molecules.Biomed. Pharmacol. J.202013257758310.13005/bpj/1920
     [Google Scholar]
  37. SavjaniK.T. GajjarA.K. SavjaniJ.K. Drug solubility: Importance and enhancement techniques.ISRN Pharm.2012201211010.5402/2012/19572722830056
     [Google Scholar]
  38. ArgadeP.S. MagarD.D. SaudagarR.B. Solid dispersion: Solubility enhancement technique for poorly water soluble drugs.J. Adv. Pharm. Educ. Res.20133427439
     [Google Scholar]
  39. KumarB. Solid dispersion: A review.Pharmatutor.201752429
     [Google Scholar]
  40. SekiguchiK. ObiN. Studies on absorption of eutectic mixture.Chem. Pharm. Bull.196191186687210.1248/cpb.9.866
     [Google Scholar]
  41. DasS.K. RoyS. KalimuthuY. KhanamJ. NandaA. Solid dispersions: An approach to enhance the bioavailability of poorly water soluble drugs.Int. J. Pharmacol. Pharm. Technol.200813746
     [Google Scholar]
  42. HudaN.H. SaffoonN. SutradharK.B. UddinR. Enhancement of oral bioavailability and solid dispersion: A review.J. App.Pharm. Sci.201111320
     [Google Scholar]
  43. JainC.P. SharmaA. Solid dispersion: A promising technique to enhance solubility of poorly water soluble drug.Int. J. Drug Deliv.20113149170
     [Google Scholar]
  44. SreeV. VaiyanaR.C. Fundamental aspects of a third component used in ternary solid dispersion: A review.Int. J. App. Pharm.2021131117
     [Google Scholar]
  45. SinghG. KaurL. GuptaG.D. SharmaS. Enhancement of the solubility of poorly water soluble drugs through solid dispersion: A comprehensive review.Indian J. Pharm. Sci.201779567468710.4172/pharmaceutical‑sciences.1000279
     [Google Scholar]
  46. KanikkannanN. Technologies to improve the solubility, dissolution and bioavailability of poorly soluble drugs.J. Anal. Pharm. Res.201871455010.15406/japlr.2018.07.00198
     [Google Scholar]
  47. DeBoyaceK. WildfongP.L.D. The application of modeling and prediction to the formation and stability of amorphous solid dispersions.J. Pharm. Sci.20181071577410.1016/j.xphs.2017.03.02928389266
     [Google Scholar]
  48. SultanaS. SaifuddinA.M.H. Solid dispersion currently practiced in pharmaceutical field.Int. J. Adv. Res. Technol.20165170175
     [Google Scholar]
  49. GreeshmikaC. KavyaP. SarahS.S. HemalathaB. PadmalathaK. Solid dispersion strategy to enhance solubility.Indo American J. Pharm. Sci.2021818121824
     [Google Scholar]
  50. GuptaM.K. SenP.P. GuptaM. Solubility enhancement of poorly water-soluble drugs using solid dispersion method a review.Int. J. Curr. Pharm. Rev. Res.2021132027
     [Google Scholar]
  51. KumarN. SahooP.K. RathoreD. Solid dispersions: A review on lyophilization and solid-state characterization of biopharmaceutical classification system class ii drugs.World J. Pharm. Pharm. Sci.20187184194
     [Google Scholar]
  52. ZhangX. XingH. ZhaoY. MaZ. Pharmaceutical dispersion techniques for dissolution and bioavailability enhancement of poorly water-soluble drugs.Pharmaceutics20181037410.3390/pharmaceutics1003007429937483
     [Google Scholar]
  53. QushawyM. NasrA. SwidanS. MortagiY. Development and characterization of glimepiride novel solid nanodispersion for improving its oral bioavailability.Sci. Pharm.20208845210.3390/scipharm88040052
     [Google Scholar]
  54. DhokaleN.N. ShaikhY. ShindeP. SisodyaP. ShaikhR. A review on: Solid dispersion.Int. J. Novel Res. Develop.20227221238
     [Google Scholar]
  55. KumarA. KumarJ. Solid dispersion techniques: A review.Int. J. Res. Eng. Sci. Manag.20214104111
     [Google Scholar]
  56. KhalidG.M. BillaN. Solid dispersion formulations by FDM 3D printing-A review.Pharmaceutics202214469010.3390/pharmaceutics1404069035456524
     [Google Scholar]
  57. BhujbalS.V. MitraB. JainU. GongY. AgrawalA. KarkiS. TaylorL.S. KumarS. Tony ZhouQ. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies.Acta Pharm. Sin. B20211182505253610.1016/j.apsb.2021.05.01434522596
     [Google Scholar]
  58. SridharI. DoshiA. JoshiB. WankhedeV. DoshiJ. Solid dispersions: An approach to enhance solubility of poorly water soluble Drug.J. Sci. Innov. Res.20132685694
     [Google Scholar]
  59. RaniK.S. PoornimaG. KrishnaveniA. BrahmaiahB. NamaS. A review on solid dispersions.Asian J. Pharm. Res.201339398
     [Google Scholar]
  60. AyushC. SahooS.C. SharmaK. Solid dispersion and its manufacturing techniques to improve bioavailability of poorly water-soluble anticancer drugs.Human202019380396
     [Google Scholar]
  61. SharmaK.S. SahooJ. AgrawalS. KumariA. Solid dispersions: A technology for improving bioavailability.J. Anal. Pharm. Res.20198412713310.15406/japlr.2019.08.00326
     [Google Scholar]
  62. PawarS.R. BarhateS.D. Solubility enhancement (Solid Dispersions) novel boon to increase bioavailability.J. Drug Deliv. Ther.20199258359010.22270/jddt.v9i2.2437
     [Google Scholar]
  63. PandaM. RaoM.E.B. PandaJ PatroG. Solid dispersion: An approach to enhance bioavailability.J. Pharm. Adv. Res.2021412611276
     [Google Scholar]
  64. NikamV.K. SheteS.K. KhapareJ.P. Most promising solid dispersion technique of oral dispersible tablet.Beni. Suef Univ. J. Basic Appl. Sci.2020916210.1186/s43088‑020‑00086‑4
     [Google Scholar]
  65. AhmedM.M. AnwerM.K. SolimanG.A. AldawsariM.F. MohammedA.A. AlshehriS. GhoneimM.M. AlaliA.S. AlshetailiA. AlalaiweA. BukhariS.I. ZafarA. Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: Micromeritics properties, release and erectile dysfunction studies in male rats.PeerJ202210e1348210.7717/peerj.1348235642201
     [Google Scholar]
  66. FarmoudehA. RezaeiroshanA. AbbaspourM. NokhodchiA. EbrahimnejadP. Solid dispersion pellets: An efficient pharmaceutical approach to enrich the solubility and dissolution rate of deferasirox.BioMed Res. Int.2020202011210.1155/2020/858354032685534
     [Google Scholar]
  67. AgungW.S. WahyuniR. OctaviaM.D. RivaiH. Review: Increased dissolution rate ofloxacin in solid dispersion systems.J. Pharm. Sci. Med.2021202163139
     [Google Scholar]
  68. ManzoorM. RazaS.A. AsimM.H. BukhariN.I. ArshadS. ZafarU. Safety and pharmaceutical evaluation of a novel natural polymer, ocicum, as solubility and dissolution enhancer in solid dispersion.Pharmaceuticals202215786910.3390/ph1507086935890167
     [Google Scholar]
  69. ChoiM.J. WooM.R. ChoiH.G. JinS.G. Effects of polymers on the drug solubility and dissolution enhancement of poorly water-soluble rivaroxaban.Int. J. Mol. Sci.20222316949110.3390/ijms2316949136012748
     [Google Scholar]
  70. TurunenE. MannilaJ. LaitinenR. RiikonenJ. LehtoV-P. JärvinenT. KetolainenJ. JärvinenK. JarhoP. Fast-dissolving sublingual solid dispersion and cyclodextrin complex increase the absorption of perphenazine in rabbits.J. Pharm. Pharmacol.2010631192510.1111/j.2042‑7158.2010.01173.x
     [Google Scholar]
  71. LiJ. LiC. ZhangH. GaoX. WangT. WangZ. ZhengA. Preparation of azithromycin amorphous solid dispersion by hot-melt extrusion: An advantageous technology with taste masking and solubilization effects.Polymers202214349510.3390/polym1403049535160485
     [Google Scholar]
  72. Al-kasmiB. AlsirawanM.H.D.B. ParadkarA. NattoufA.H. El-ZeinH. Aqueous and pH dependent coacervation method for taste masking of paracetamol via amorphous solid dispersion formation.Sci. Rep.2021111890710.1038/s41598‑021‑88312‑633903654
     [Google Scholar]
  73. SulthanaM.A. KethavathM. AhmadF. Al-SubaieA.M. Formulation development and in vitro evaluation of elvitegravir sustained release using solid dispersions.Res. J. Pharm. Technol.202013125909591310.5958/0974‑360X.2020.01031.8
     [Google Scholar]
  74. ShahP.J. PatelM.P. ShahJ. NairA.B. KottaS. VyasB. Amalgamation of solid dispersion and melt adsorption techniques for augmentation of oral bioavailability of novel anticoagulant rivaroxaban.Drug Deliv. Transl. Res.202212123029304610.1007/s13346‑022‑01168‑935467325
     [Google Scholar]
  75. PasarkarN. WaghmareS. KambleH. Solid dispersion : A review.Iconic Res. Eng. J.202257075
     [Google Scholar]
  76. AlwossabiA.M. ElaminE.S. AhmedE.M.M. AbdelrahmanM. Solubility enhancement of some poorly soluble drugs by solid dispersion using Ziziphus spina-christi gum polymer.Saudi Pharm. J.202230671172510.1016/j.jsps.2022.04.00235812143
     [Google Scholar]
  77. MankarS.D. RachP.R. Solubility enhancement of poor water-soluble drugs by solid dispersion: A review.J. Drug Deliv. Ther.201885444910.22270/jddt.v8i5.1887
     [Google Scholar]
  78. BindhaniS. MohapatraS. Recent approaches of solid dispersion: a new concept towards oral bioavailability.Asian J. Pharm. Clin. Res.201811727810.22159/ajpcr.2018.v11i2.23161
     [Google Scholar]
  79. BabuN.R. NagpalD. AnkolaD. AwasthiR. Evolution of solid dispersion technology: Solubility enhancement using hydroxypropyl methylcellulose acetate succinate: Myth or reality?Assay Drug Dev. Technol.202220414916310.1089/adt.2022.01635723615
     [Google Scholar]
  80. JadhavP.A. JadhavS.A. A review on solid dispersion: Solubility enhancer.Int. J. Innov. Pharm. Sci. Res.20175162171
     [Google Scholar]
  81. DixitA.K. SinghR.P. Solid dispersion: A strategy for improving the solubility of poorly soluble drugs.IJRPBS20123960966
     [Google Scholar]
  82. SinghS. BaghelR.S. YadavL. A review on solid dispersion.Int. J. Pharm. & Life Sci.2011210781095
     [Google Scholar]
  83. ThakurD. SharmaR. Solid dispersion a novel approach for enhancement of solubility and dissolution rate: A review.Ind. J. Pharmac. Biol. Res.201973051110.30750/ijpbr.7.3.2
     [Google Scholar]
  84. YadavB. TanwarY.S. Applications of solid dispersions.J. Chem. Pharm. Res.20157965978
     [Google Scholar]
  85. AsatiA.V. SalunkheK.S. ChavanM.J. ChintamaniR.B. SinghR.P. Solubility enhancement of BCS classified ii/iv drug : Solid dispersion of apixaban by solvent evaporation.Int. J. Pharm. Investig.202010443043610.5530/ijpi.2020.4.76
     [Google Scholar]
  86. HelsintaN. HalimA. OctaviaM.D. RivaiH. Review: solid dispersion of fenofibrate using poly ethylene glycol 6000.Int.J. Chem. Pharm. Res.med.202166425110.47760/ijpsm.2021.v06i06.005
     [Google Scholar]
  87. KedarA.K. KulkarniA.D. Binary amorphous solid dispersion: Methods and applications.J. Emerg. Technol. Innov. Res.20202685698
     [Google Scholar]
  88. Salah AttiaM. Ali HasanA. GhazyF.E.S. GomaaE. Solid dispersion as a technical solution to boost the dissolution rate and bioavailability of poorly water-soluble drugs.Ind.J. Pharmac. Educ. Res.2021552ss327s33910.5530/ijper.55.2s.103
     [Google Scholar]
  89. MirK.S. KhanA.K. Solid dispersion: Overview of the technology.Int. J. Pharm. Sci. Res.2017823782387
     [Google Scholar]
  90. TranP. PyoY.C. KimD.H. LeeS.E. KimJ.K. ParkJ.S. Overview of the manufacturing methods of solid dispersion technology for improving the solubility of poorly water-soluble drugs and application to anticancer drugs.Pharmaceutics201911313210.3390/pharmaceutics1103013230893899
     [Google Scholar]
  91. GuntakaP.R. LankalapalliS. Solid dispersion: A novel approach for bioavailability enhancement of poorly water-soluble drugs in solid oral dosage forms.Asian J. Pharm. Clin. Res.201912172610.22159/ajpcr.2019.v12i2.29157
     [Google Scholar]
  92. MustafaW.W. FletcherJ. KhoderM. AlanyR.G. Solid dispersions of gefitinib prepared by spray drying with improved mucoadhesive and drug dissolution properties.AAPS Pharm Sci Tech20222314810.1208/s12249‑021‑02187‑434984564
     [Google Scholar]
  93. TekadeA.R. YadavJ.N. A review on solid dispersion and carriers used therein for solubility enhancement of poorly water soluble drugs.Adv. Pharm. Bull.202010335936910.34172/apb.2020.04432665894
     [Google Scholar]
  94. GoldbergA.H. GalbaldiM. KaningK.L. Increasing in resolution rates and gastrointestinal via solid solution and eutectic mixture experimental evaluation of griseofulvin-succinic acid solution.J. Pharm. Sci.19665548704920
     [Google Scholar]
  95. LimaA.A.N. SantosP.B.S. LyraM.A.M. dos SantosF.L.A. Rolim-NetoP.J. Solid dispersion systems for increase solubility: Cases with hydrophilic polymers in poorly water soluble drugs.Rev. Bras. Farm.201192269278
     [Google Scholar]
  96. BakatselouV. OppenheimR.C. DressmanJ.B. Solubilization and wetting effects of bile salts on the dissolution of steroids.Pharm. Res.19918121461146910.1023/A:10158779293811808607
     [Google Scholar]
  97. BetageriG. MakarlaK.R. Enhancement of dissolution of glyburide by solid dispersion and lyophilization techniques.Int. J. Pharm.19951261-215516010.1016/0378‑5173(95)04114‑1
     [Google Scholar]
  98. HörterD. DressmanJ.B. Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract.Adv. Drug Deliv. Rev.199725131410.1016/S0169‑409X(96)00487‑5
     [Google Scholar]
  99. MoyanoJ.R. Arias-BlancoM.J. GinésJ.M. GiordanoF. Solid-state characterization and dissolution characteristics of gliclazide-β-cyclodextrin inclusion complexes.Int. J. Pharm.1997148221121710.1016/S0378‑5173(96)04848‑X
     [Google Scholar]
  100. DeitzelJ.M. KleinmeyerJ. HarrisD. Beck TanN.C. The effect of processing variables on the morphology of electrospun nanofibers and textiles.Polymer200142126127210.1016/S0032‑3861(00)00250‑0
     [Google Scholar]
  101. RasenackN. HartenhauerH. MüllerB.W. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs.Int. J. Pharm.2003254213714510.1016/S0378‑5173(03)00005‑X12623189
     [Google Scholar]
  102. TsinontidesS.C. RajniakP. PhamD. HunkeW.A. PlacekJ. ReynoldsS.D. Freeze drying—principles and practice for successful scale-up to manufacturing.Int. J. Pharm.20042801-211610.1016/j.ijpharm.2004.04.01815265542
     [Google Scholar]
  103. VilhelmsenT. EliasenH. SchæferT. Effect of a melt agglomeration process on agglomerates containing solid dispersions.Int. J. Pharm.20053031-213214210.1016/j.ijpharm.2005.07.01216139973
     [Google Scholar]
  104. KalaiselvanR. MohantaG.P. MannaP.K. ManavalanR. Studies on mechanism of enhanced dissolution of albendazole solid dispersions with crystalline carriers.Indian J. Pharm. Sci.200668559960710.4103/0250‑474X.29627
     [Google Scholar]
  105. KaranthH. ShenoyV.S. MurthyR.R. Industrially feasible alternative approaches in the manufacture in the solid dispersion: A technical report.AAPS PharmSciTech20077487
     [Google Scholar]
  106. NokhodchiA. TalariR. ValizadehH. JalaliM.B. An investigation on the solid dispersions of chlordiazepoxide.Int. J. Biomed. Sci.20073321121623675046
     [Google Scholar]
  107. SharmaD.K. JoshiS.B. Solubility enhancement strategies for poorly water soluble drugs in solid dispersion.Asian J. Pharm.2007178
     [Google Scholar]
  108. ZhangW. YanE. HuangZ. WangC. XinY. ZhaoQ. TongY. Preparation and study of PPV/PVA nanofibers via electrospinning PPV precursor alcohol solution.Eur. Polym. J.200743380280710.1016/j.eurpolymj.2006.11.015
     [Google Scholar]
  109. BhiseS.B. RajkumarM. Effect of HPMC on solubility and dissolution of carbamazepine form III in simulated gastrointestinal fluids.Asian J. Pharm.200821384210.4103/0973‑8398.41564
     [Google Scholar]
  110. DhirendraK. LewisS. UdupaN. AtinK. Solid dispersions: A review.Pak. J. Pharm. Sci.200922223424619339238
     [Google Scholar]
  111. SayyadA. SawantS.D. Techniques of solubility enhancement of poorly soluble drug with special emphasis on solid dispersion.J. Pharm. Res.2010324942501
     [Google Scholar]
  112. AlamM.A. AliR. Al-JenoobiF.I. Al-MohizeaA.M. Solid dispersions: A strategy for poorly aqueous soluble drugs and technology updates.Expert Opin. Drug Deliv.20129111419144010.1517/17425247.2012.73206423043303
     [Google Scholar]
  113. NiranjanC. SidharthP. JagdishS. AnuradhaC. A complete review on solid dispersion technology and factorial design.J. Curr. Pharma. Res.20122465966710.33786/JCPR.2012.v02i04.011
     [Google Scholar]
  114. GhoshP.K. SharmaH.K. BoruahN. Different methods used in solid dispersion.IOSR J. Pharm.201882838
     [Google Scholar]
  115. HimanshuH. DeepakS. KumarG. A mini review on solubility enhancement technique: Solid dispersion.Asian Pacif. J. Heal. Sci.20185313214610.21276/apjhs.2018.5.3.19
     [Google Scholar]
  116. CidA.G. SimonazziA. PalmaS.D. BermúdezJ.M. Solid dispersion technology as a strategy to improve the bioavailability of poorly soluble drugs.Ther. Deliv.201910636338210.4155/tde‑2019‑000731094298
     [Google Scholar]
  117. AnsariM.J. An overview of techniques for multifold enhancement in solubility of poorly soluble drugs.Curr. Issues Pharm. Med. Sci.201932420320910.2478/cipms‑2019‑0035
     [Google Scholar]
  118. LaFountaineJ.S. McGinityJ.W. WilliamsR.O.III Challenges and strategies in thermal processing of amorphous solid dispersions: A review.AAPS PharmSciTech2016171435510.1208/s12249‑015‑0393‑y26307759
     [Google Scholar]
  119. AlshehriS. ImamS.S. HussainA. AltamimiM.A. AlruwailiN.K. AlotaibiF. AlanaziA. ShakeelF. RETRACTED ARTICLE: Potential of solid dispersions to enhance solubility, bioavailability, and therapeutic efficacy of poorly water-soluble drugs: Newer formulation techniques, current marketed scenario and patents.Drug Deliv.20202711625164310.1080/10717544.2020.184663833207947
     [Google Scholar]
  120. RathiK.S. AhirraoS. KshirsagarS. Review article: Solubility enhancement by solid dispersion.Indian J. Drugs.20186165173
     [Google Scholar]
  121. KarolewiczB. GórniakA. OwczarekA. NartowskiK. Zurawska-PłaksejE. PlutaJ. Solid dispersion in pharmaceutical technology. Part II. The methods of analysis of solid dispersions and examples of their application.Polim. Med.20124229710723016440
     [Google Scholar]
  122. ChadhaR. KapoorV.K. KumarA. Analytical techniques used to characterize drug polyvinylpyrrolidone systems in solids and liquid states- an overview.J. Sci. Ind. Res.200665459469
     [Google Scholar]
  123. ChiouW.L. RiegelmanS. Pharmaceutical applications of solid dispersion systems.J. Pharm. Sci.19716091281130210.1002/jps.26006009024935981
     [Google Scholar]
  124. DeshmaneS.V. BiyaniK.R. Characterization of solid dispersion: A review.ARPB20144584589
     [Google Scholar]
  125. GreeshmikaC. KavyaP. SarahS.S. HemalathaB. PadmalathaK. Solid dispersion: Strategy to enhance solubility.IAJPS2021818121824
     [Google Scholar]
  126. HuangY. DaiW.G. Fundamental aspects of solid dispersion technology for poorly soluble drugs.Acta Pharm. Sin. B201441182510.1016/j.apsb.2013.11.00126579360
     [Google Scholar]
  127. LiuX. FengX. WilliamsR.O. ZhangF. Characterization of amorphous solid dispersions.J. Pharm. Investig.2017
     [Google Scholar]
  128. MaX. WilliamsR.O.III Characterization of amorphous solid dispersions: An update.J. Drug Deliv. Sci. Technol.20195011312410.1016/j.jddst.2019.01.017
     [Google Scholar]
  129. NikghalbL.A. SinghG. SinghG. KahkeshanK.F. Solid dispersion: methods and polymers to increase the solubility of poorly soluble drugs.J. Appl. Pharm. Sci.20122170175
     [Google Scholar]
  130. GoldenP. KabirM.A. Solid dispersion forms of Rifaximin.US Patent 2021401813A12021
  131. SangwookK. Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same.KR102104507B12020
  132. ShanmugamS. TekI.M.K. SuY.E. JongK. KhyunP.D. SuU.D. Amorphous solid dispersion comprising taxane, tablet comprising same, and method for preparing same.KR102104507B12019
  133. PawarA.A. ReddyP. ReddyS. MudapakaV.K. GopiS.P. ReddyK.R.S. VermaH. Amorphous solid dispersions of apalutamide and process for the preparation thereof.WO2019016747A12018
  134. HarrisD. DiNunzioJ. MarinaroW.A. SotthiviratS. BrownC.D. DhareshwarS.S. KuiperJ.L. LeeY.C. McKelveyC.A. McnevinM. MillerE.T. XiongL. Fixed-dose combinations of antiviral compounds.US Patent 2018/0228826A12018
  135. WolffH.M. ArthC. QuereL. MullerW. Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of Rotigotine.US Patent 1030589B22018
  136. WangH. FanY. ChenX. ChenX. Solid dispersion of decoquinate preparation process and its application.US Patent 0360708A12017
  137. WangX. LiL. XuY. LiJ. TuR. ChenG. CaoR. FengY. YangZ. FanZ. YuY. XiaoQ. HuangL. YangC. HuangT. TianH. YangJ. Solid dispersion containing desmodium Styracifolium Merr. flavonoids, method of preparing same, and use thereof.US Patent 0028007A12017
  138. ShenzhenV.G. ShenzhenB.S. Allisartan isoproxil solid dispersion and pharmaceutical composition comprising same.EP0157095A12017
  139. SrinivasanS. HoT.I.M. YoonY.S. KimY.I. ParkJ.H. WooJ.S. Amorphous solid dispersion comprising taxane, tablet comprising the same, and method for preparing the same.US Patent 2017/0112799A12017
  140. BaekM.K. PeganA. Solid dispersions of insoluble drug and preparation method thereof.US Patent 9724335B22017
  141. BattungF. Pierre-YvesJ. HecqJ. ColinA. Solid dispersion of a selective modulator of the progesterone receptor.US Patent 0213684A12016
  142. QuettiM. Solid dispersion of a selective modulator of the progesterone receptor.US Patent 0213684A12016
  143. EngersD.A. YonglaiY. HoustonT. FriedmanB.C. Solid dispersions of amorphous paroxetine mesylate.US Patent 9211290B22015
  144. MinmiA.B. Solid dispersion containing dutasteride and composition containing the solid dispersion.KR Patent 101561406B12015
  145. MogalianE. OliyaiR. StefanidisD. ZiaV. Solid disperson formulation of an antiviral compound.US Patent 2014/0212487A12014
  146. ReddyP. ReddyR. ReddyM. ReddyS.C. KrishnaV. Elvitegravir solid dispersion.WO Patent 2013/175505Al2013
  147. ChenA.X. FanJ. YamaguchiM. Solid dispersion of Alpha-ketoamide dervatives.US Patent 2012/0016020A12012
  148. WatanabeS. TakemuraS. TsutsuiY. KondoH. NakanishiK. SakoK. SawadaT. Pharmaceutical composition for oral use with improved absorption.US Patent 7871644B22011
  149. HolmP. NorlingT. Solid dispersions comprising tacrolimus.US Patent 2011/0263632A12011
  150. VerreckG. BaertL. Antiviral compositions.US Patent 7887845B22011
  151. A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets.Available from: https://clinicaltrials.gov/ct2/show/NCT04065932?cond=Solid+dispersion+tablets&draw=2&rank=1 (Accessed July 21, 2021)
  152. Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE) (OHE).Available from: https://clinicaltrials.gov/ct2/show/record/NCT03515044?cond=Solid+dispersion+tablets&draw=2&rank=2 (Accessed July 21, 2021)
  153. Dose-ranging Study of Rifaximin Soluble Solid Dispersion (SSD) Tablets for the Prevention of Complications of Early Decompensated Liver Cirrhosis.Available from: https://clinicaltrials.gov/ct2/show/NCT01904409?cond=Solid+dispersion+tablets&draw=2&rank=3 (Accessed July 22, 2021)
  154. Bioavailability Mechanistic Study of Hot-Melt Extruded Amorphous Solid Dispersions (BEAD).Available from: https://clinicaltrials.gov/ct2/show/NCT03886766?term=%22solid+dispersion%22&draw=3&rank=1 (Accessed July 22, 2021)
  155. Oral Bioavailability of GLPG0555 in Different Solid Formulations.Available from: https://clinicaltrials.gov/ct2/show/NCT01278095?term=%22solid+dispersion%22&draw=3&rank=2 (Accessed August 5, 2021)
  156. Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria.Available from: https://clinicaltrials.gov/ct2/show/NCT03167242?term=%22solid+dispersion%22&draw=3&rank=5 (Accessed August 29, 2021)
  157. A Study of LY2484595 in Healthy Subjects.Available from: https://clinicaltrials.gov/ct2/show/NCT01450098?term=%22solid+dispersion%22&draw=3&rank=7 (Accessed September 2, 2021)
  158. Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers (ASDBioequiv).Available from: https://clinicaltrials.gov/ct2/show/record/NCT02341274?term=%22solid+dispersion%22&draw=3&rank=8 (Accessed September 2, 2021)
  159. BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy.Available from: https://clinicaltrials.gov/ct2/show/NCT01658436?term=%22solid+dispersion%22&draw=3&rank=9 (Accessed September 2, 2021)
  160. TAK-020 Relative Bioavailability and Food Effect Study in Healthy Participants. https://clinicaltrials.gov/ct2/show/NCT02723201?term=%22solid+dispersion%22&draw=3&rank=10 (Accessed September 2, 2021)
  161. Studying Different Formulations of SR13668 in Healthy Volunteers.Available from: https://clinicaltrials.gov/ct2/show/NCT00896207?term=%22solid+dispersion%22&draw=3&rank=11 (Accessed September 2, 2021)
  162. Safety and Efficacy of DNK333 in Atopic Dermatitis Patients.Available from: https://clinicaltrials.gov/ct2/show/NCT01033097?term=%22solid+dispersion%22&draw=3&rank=12 (Accessed September 2, 2021)
  163. PrasadE. RobertsonJ. HalbertG.W. Mefenamic acid solid dispersions: Impact of formulation composition on processing parameters, product properties and performance.Int. J. Pharm.202261612150510.1016/j.ijpharm.2022.12150535085732
     [Google Scholar]
  164. ShiX. XiangjunF. BaibaiZ. ChenX. ShenQ. XingS. DengX. Preparation and characterization of ibrutinib amorphous solid dispersions: A discussion of interaction force.J. Pharm. Innov.202116110
     [Google Scholar]
  165. HarmelyF. UmarS. AldiY. NasrulE. ZainiE. Preparation and physicochemical characterization of solid dispersion of irbesartan with poloxamer 188.J. Med. Sci.202081619
     [Google Scholar]
  166. ZengQ. OuL. ZhaoG. CaiP. LiaoZ. DongW. LiangX. Preparation and characterization of PEG4000 palmitate/PEG8000 palmitate-solid dispersion containing the poorly water-soluble drug andrographolide.Adv. Polym. Technol.202020201710.1155/2020/4239207
     [Google Scholar]
  167. AraliB. KumarA. SettyM. An approach to enhance dissolution rate of rilpivirine by solid dispersion technique.J. Pharm. Sci. & Res.20191131453152
     [Google Scholar]
  168. MohammadiH. KumarV.H. Formulation and evaluation of solid dispersion incorporated fast disintegrating tablets of tenoxicam using design of experiment.Int. J. Pharm. Sci. Drug Res.2019111354410.25004/IJPSDR.2019.110106
     [Google Scholar]
  169. AlshehriS.M. ShakeelF. IbrahimM.A. ElzayatE.M. AltamimiM. MohsinK. AlmeanazelO.T. AlkholiefM. AlshetailiA. AlsulaysB. AlanaziF.K. AlsarraI.A. Dissolution and bioavailability improvement of bioactive apigenin using solid dispersions prepared by different techniques.Saudi Pharm. J.201927226427310.1016/j.jsps.2018.11.00830766439
     [Google Scholar]
  170. UegakiN. HiraiT.N. TakataniK. Takahashi. Preparation and evaluation of controlled-release solid dispersion granules containing a poorly water-soluble drug, hydrated silicon dioxide, and polyvinylpyrrolidone.J. Pharmaceu. Pharmacol.20197207909171
     [Google Scholar]
  171. AlamA. DasS.S. HussainA. FarukA. Formulation and evaluation of solid dispersion and inclusion complex of poorly aqueous soluble diacerein.J. Material Sci.2018519
     [Google Scholar]
  172. KhatriP. ShahM.K. PatelN. JainS. VoraN. LinS. Preparation and characterization of pyrimethamine solid dispersions and an evaluation of the physical nature of pyrimethamine in solid dispersions.J. Drug Deliv. Sci. Technol.20184511012310.1016/j.jddst.2018.03.012
     [Google Scholar]
  173. SankariT. Al-HaririS. Preparation and characterization of cefuroxime axetil solid dispersions using poloxamer 188.Braz. J. Pharm. Sci.2018544e1764410.1590/s2175‑97902018000417644
     [Google Scholar]
  174. SupriyaA. ManasaB. ShilpaT.N. KazaR. SavithrammaS. PrasaduD. Dissolution improvement of telmisartan by surface solid dispersion method.ASPS2018212428
     [Google Scholar]
  175. SimonazziA. CidA.G. ParedesA.J. SchofsL. GonzoE.E. PalmaS.D. BermúdezJ.M. Development and in vitro evaluation of solid dispersions as strategy to improve albendazole biopharmaceutical behavior.Ther. Deliv.20189962363810.4155/tde‑2018‑003730189808
     [Google Scholar]
  176. WahabA. KhanG.M. SharifiM. KhanA. KhanA. KhanN. Preparation, solid state characterization and evaluation of ketoprofen glucosamine HCl solid dispersions.Arch. Pharm. Pharma. Sci.201821019
     [Google Scholar]
  177. ChowdhuryR. AnjumR. SiddiquiS.A. RahmanZ. SharminT. MamunM. Formulation and evaluation of aceclofenac solid dispersion for improving the solubility and dissolution rate.Int. J. Pharm. Sci. Invent.201863034
     [Google Scholar]
  178. AdeliE. Preparation and evaluation of azithromycin binary solid dispersions using various polyethylene glycols for the improvement of the drug solubility and dissolution rate.Braz. J. Pharm. Sci.201652111310.1590/S1984‑82502016000100002
     [Google Scholar]
  179. Al-HamidiH. ObeidatW.M. NokhodchiA. The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.Pharm. Dev. Technol.2015201748310.3109/10837450.2013.87102924392858
     [Google Scholar]
  180. DaniP. PuriV. BansalA.K. Solubility advantage from amorphous etoricoxib solid dispersions.Drug Dev. Ind. Pharm.20144019210110.3109/03639045.2012.74988723301771
     [Google Scholar]
  181. KhalilR.M. GhorabM.M. Abd E RahmanN. El-AriniSK. Characterization of ternary solid dispersions of nimesulide with Inutec SP1 and β-cyclodextrin and evaluation of anti-inflammatory efficiency in rats.Egyptian Pharm. J.20131214656
     [Google Scholar]
  182. WeliA.M. SaddarE. HiremathJ.G. BalamuruganM. Preparation and characterization of benzathine penicillin G solid dispersions using different hydrophilic carriers.Int. J. Drug Deliv.20135420429
     [Google Scholar]
  183. KreidelR.N. DuqueM.D. SerraC.H.R. VelascoM.V.R. BabyA.R. KanekoT.M. ConsiglieriV.O. Dissolution enhancement and characterization of nimodipine solid dispersions with poloxamer 407 or PEG 6000.J. Dispers. Sci. Technol.20123391354135910.1080/01932691.2011.605663
     [Google Scholar]
  184. SinghS.K. SomS. ShankhwarU. Formulation and optimization of solid dispersion of Clopidogrel with PEG 6000.J. Appl. Pharm. Sci.20111217226
     [Google Scholar]
  185. ChenH. PuiY. LiuC. ChenZ. SuC.C. HagemanM. HussainM. HaskellR. StefanskiK. FosterK. GudmundssonO. QianF. Moisture-induced amorphous phase separation of amorphous solid dispersions: Molecular mechanism, microstructure, and its impact on dissolution performance.J. Pharm. Sci.2018107131732610.1016/j.xphs.2017.10.02829107047
     [Google Scholar]
  186. IyerR. Petrovska JovanovskaV. BergincK. JakličM. FabianiF. HarlacherC. HuzjakT. Sanchez-FelixM.V. FelixS. Amorphous solid dispersions: The influence of material properties, manufacturing processes and analytical technologies in drug product development.Pharmaceutics20211310168210.3390/pharmaceutics1310168234683975
     [Google Scholar]
  187. JanssensS. Van den MooterG. Review: physical chemistry of solid dispersions.J. Pharm. Pharmacol.201061121571158610.1211/jpp.61.12.000119958579
     [Google Scholar]
  188. JelićD. Thermal stability of amorphous solid dispersions.Molecules202126123810.3390/molecules2601023833466393
     [Google Scholar]
/content/journals/nanotec/10.2174/0118722105229356231030065938
Loading
Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs
Recent Pat Nanotechnol 19, 216 (2025); https://doi.org/10.2174/0118722105229356231030065938
/content/journals/nanotec/10.2174/0118722105229356231030065938
/content/journals/nanotec/10.2174/0118722105229356231030065938
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): commercial products; dissolution rate improvement; drug delivery systems; solid dispersion; Solubility; water-soluble drugs

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test